Drugs@FDA document

DURLAZA Letter · NDA 200671 ORIG-1

Drugs@FDA document · HESP · Sep 15, 2015

Key facts

Drug name DURLAZA
Document type Letter
Application NDA200671
Submission ORIG-1
Company HESP
Document date Sep 15, 2015
FDA document accessdata.fda.gov

At a glance

  • 10–99 Documents for this application
  • None USP chapters cited in this application's documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents